Early acceptability of a mobile app for contact tracing during the COVID-19 pandemic in France: national web-based survey R Touzani, E Schultz, SM Holmes, S Vandentorren, P Arwidson, ... JMIR mHealth and uHealth 9 (7), e27768, 2021 | 30 | 2021 |
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience S Besle, E Schultz, A Hollebecque, A Varga, C Baldini, P Martin, ... European Journal of Cancer 98, 17-22, 2018 | 19 | 2018 |
Le temps d'un projet. Les temporalités du financement sur projet dans un laboratoire de biophysique É Schultz Temporalités. Revue de sciences sociales et humaines, 2013 | 18 | 2013 |
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 É Schultz, L Atlani-Duault, P Peretti-Watel, JK Ward Therapies 77 (5), 591-602, 2022 | 16 | 2022 |
Science under Covid-19’s magnifying glass: Lessons from the first months of the chloroquine debate in the French press É Schultz, JK Ward Journal of sociology 58 (1), 76-94, 2022 | 16 | 2022 |
Construire une économie de la recherche sur projets. L’installation de l’Agence nationale de la recherche en France et ses conséquences dans les domaines de la génomique … E Schultz Université Paris Sorbonne, 2016 | 16 | 2016 |
Les innovations d’intelligence artificielle en radiologie à l’épreuve des régulations du système de santé L Mignot, É Schultz Reseaux 232233 (2), 65-97, 2022 | 15 | 2022 |
L’ANR en ph (r) ase critique. Figures et déterminants de la critique d’un dispositif de financement J Giry, É Schultz Zilsel 2 (2), 63-96, 2017 | 14 | 2017 |
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study E Charton, C Baldini, Y Fayet, E Schultz, L Auroy, E Vallier, A Italiano, ... ESMO open 8 (4), 101610, 2023 | 13 | 2023 |
Utiliser la recherche pour soigner le cancer: l’innovation biomédicale localisée S Besle, É Schultz Revue française de sociologie, 405-433, 2020 | 13 | 2020 |
French public familiarity and attitudes toward clinical research during the COVID-19 pandemic É Schultz, JK Ward, L Atlani-Duault, SM Holmes, J Mancini International Journal of Environmental Research and Public Health 18 (5), 2611, 2021 | 12 | 2021 |
From contact tracing to COVID-19 pass holder; the tortured journey of the French TousAntiCovid contact tracing app É Schultz, R Touzani, J Mancini, JK Ward Public Health 206, 5-7, 2022 | 11 | 2022 |
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study C Baldini, E Charton, E Schultz, L Auroy, A Italiano, M Robert, E Coquan, ... ESMO open 7 (3), 100468, 2022 | 10 | 2022 |
Public perceptions of scientific advice: toward a science savvy public culture? É Schultz, JK Ward Public health 194, 86-88, 2021 | 10 | 2021 |
La régulation de la pertinence thérapeutique des essais précoces en cancérologie L Auroy, S Besle, É Schultz Revue française des affaires sociales, 53-70, 2019 | 9 | 2019 |
Information overload in the context of COVID-19 pandemic: A repeated cross-sectional study M Breyton, É Schultz, A Rouquette, J Mancini Patient Education and Counseling 110, 107672, 2023 | 8 | 2023 |
Les parcours de soins des enfants en rechute de cancer. Un objet multi-situé au croisement de la sociologie et de la médecine S Besle, S Carof, É Schultz Espaces et sociétés, 73-88, 2019 | 7 | 2019 |
4. L’institutionnalisation progressive des essais précoces en France S Besle, É Schultz Les politiques de lutte contre le cancer en France, 81-98, 2019 | 6 | 2019 |
Conserver un aliment vivant. Entretien et circulation d’un ferment: le cas du Kéfir R Debailly, C Lavelle, É Schultz Techniques & Culture. Revue semestrielle d’anthropologie des techniques, 2018 | 6 | 2018 |
Digital contact tracing during the COVID-19 pandemic in France: Associated factors and reasons for non-use R Touzani, E Schultz, S Vandentorren, P Arwidson, F Guillemin, ... International Journal of Medical Informatics 171, 104994, 2023 | 4 | 2023 |